Key Developments: CryoLife Inc (CRY)

CRY on New York Consolidated

10.03USD
24 Jul 2014
Price Change (% chg)

$0.87 (+9.50%)
Prev Close
$9.16
Open
$9.12
Day's High
$10.10
Day's Low
$9.08
Volume
325,796
Avg. Vol
121,482
52-wk High
$12.14
52-wk Low
$6.01

Search Stocks

Latest Key Developments (Source: Significant Developments)

CryoLife Inc reaffirms FY 2014 EPS outlook; raises FY 2014 revenue outlook
8:08am EDT 

CryoLife Inc:Expects FY 2014 total revenues in the range of $144 -$146 mln, as compared to previous range of $146 -$150 mln.Expects FY 2014 earnings per share in the range of $0.17 - $0.20, including litigation, unchanged.FY 2014 revenue of $147 mln, EPS of $0.20 - Thomson Reuters I/B/E/S.  Full Article

CryoLife Inc appoints President and Chief Executive Officer
Thursday, 10 Jul 2014 08:00am EDT 

CryoLife Inc:Directors has appointed James Patrick (Pat) Mackin as President and Chief Executive Officer, effective Sep. 2.Mackin is expected to be appointed to Co's Board of Directors after his employment begins.  Full Article

CryoLife Inc increases quarterly cash dividend nine percent for the second quarter 2014
Thursday, 22 May 2014 05:00pm EDT 

CryoLife Inc:Approves nine percent increase in quarterly cash dividend for second quarter 2014 from $0.0275 to $0.03 per share of common stock outstanding.At new rate, indicated dividend on an annual basis is $0.12 per share compared to the previous rate of $0.11 per share.Quarterly cash dividend of $0.03 per share will be paid on June 20, 2014 to all common stockholders of record as of June 13, 2014.Ex-dividend date for the quarterly dividend is June 11, 2014.  Full Article

CryoLife Inc reaffirms FY 2014 revenue guidance; lowers FY 2014 EPS guidance
Tuesday, 29 Apr 2014 08:14am EDT 

CryoLife Inc:Reaffirms FY 2014 revenue guidance in the range of $146-$150 mln.Revises FY 2014 EPS guidance to a range of $0.17-$0.20, including litigation (prior FY 2014 EPS guidance was in the range of $0.21-$0.24).FY 2014 revenue of $149 mln and EPS of $0.26 - Thomson Reuters I/B/E/S.  Full Article

CryoLife Inc receives FDA 510(k) clearance for PerClot Topical Hemostatic Powder in US
Tuesday, 29 Apr 2014 08:04am EDT 

CryoLife Inc:It has received 510(k) clearance for PerClot Topical hemostatic powder from the US FDA.Clearance allows CryoLife to begin commercialization of PerClot Topical hemostatic powder in US.Company plans to begin shipping PerClot Topical hemostatic powder in June of this year.  Full Article

CryoLife receives FDA approval to begin clinical trials for PerClot in the U.S
Wednesday, 2 Apr 2014 08:32am EDT 

CryoLife Inc:Receives approval of its Investigational Device Exemption (IDE) for PerClot from the United States Food and Drug Administration.Approval allows CryoLife to begin its pivotal clinical trial to gain approval to commercialize PerClot in the U.S.  Full Article

CryoLife Inc acquires distribution rights and purchase option for ProCol Vascular Bioprosthesis for Hemodialysis Access
Thursday, 27 Mar 2014 08:34am EDT 

CryoLife Inc:Acquires worldwide distribution rights for ProCol Vascular Bioprosthesis from Hancock Jaffe Laboratories, Inc.Beginning 24 months after execution of agreement, CryoLife has right to acquire ProCol product line from Hancock Jaffe.  Full Article

CryoLife Inc gives FY 2014 guidance; EPS guidance below analysts' estimates
Thursday, 20 Feb 2014 08:04am EST 

CryoLife Inc:Expects FY 2014 total revenues of $146 million - $150 million.Expects FY 2014 earnings per share of $0.21 - $0.24.FY 2014 revenue of $150 million and EPS of $0.38 - Thomson Reuters I/B/E/S.  Full Article

CryoLife Inc announces quarterly cash dividend for the first quarter 2014
Wednesday, 19 Feb 2014 05:06pm EST 

CryoLife Inc:Approves a quarterly cash dividend for the first quarter 2014 of $0.0275 per share of common stock outstanding.Quarterly cash dividend of $0.0275 per share will be paid on March 21 to all common stockholders of record as of March 14.  Full Article

CryoLife Inc announces expansion in asia pacific markets
Tuesday, 18 Feb 2014 08:34am EST 

CryoLife Inc:Says establishment of CryoLife Asia Pacific Pte. Ltd., a subsidiary of CryoLife Inc. to expand the company's presence in the rapidly growing Asia Pacific medical device market.  Full Article

Search Stocks